Top 5 New Drug Launches of 2019 -- and the Biotech Stocks That Could Win Big

Market research company EvaluatePharma analyzed all of the drugs that could launch in 2019. The company then projected how much each drug could potentially generate by 2024. Alexion Pharmaceuticals (NASDAQ:ALXN), AbbVie (NYSE:ABBV), Aimmune Therapeutics (NASDAQ:AIMT), and bluebird bio (NASDAQ:BLUE) came out on top in EvaluatePharma's ranking of the top five new drug launches expected this year. Here are the drugs that made the list.